Kriti Nutrients Ltd. Holds 30th AGM on Aug 12, 2026; Approves Key Resolutions
Kriti Nutrients Limited held its 30th AGM on August 12, 2026. The company adopted its FY26 financial statements and confirmed an interim dividend of ₹3.00 per share. Key appointments and remuneration changes for directors and auditors were approved. The AGM was conducted via VC/OAVM.
The AGM outcomes, including financial approvals and director re-appointments with remuneration adjustments, are significant for the company's governance and operational continuity. These decisions have a medium-term impact on the company's strategic direction and management structure.
The announcement details the successful conclusion of the Annual General Meeting with all resolutions, including financial statement adoption, dividend confirmation, and key personnel re-appointments/remuneration adjustments, passing with a requisite majority. This indicates smooth corporate governance and shareholder approval.
Kriti Nutrients Limited convened its 30th Annual General Meeting (AGM) on Wednesday, August 12, 2026, conducted virtually via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting, which commenced at 4:30 P.M. IST and concluded at 5:01 P.M. IST, saw the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Shareholders also confirmed the interim dividend of ₹3.00 (300%) per equity share for the financial year 2025-26, amounting to ₹1503.11 Lakhs.
Key personnel appointments and re-appointments were approved, including the re-appointment of Mr. Saurabh Singh Mehta as a Director and the re-appointment of M/s M Mehta & Company as Statutory Auditors for a five-year term until the 35th AGM in 2031. The remuneration payable to the Cost Auditors, M/s. Dhananjay V. Joshi & Associates, for the year 2026-27 was ratified at ₹35,000 plus applicable taxes and expenses.
Furthermore, special resolutions were passed regarding the revision in remuneration for Mr. Saurabh Singh Mehta, designated as Joint Managing Director, for the period April 1, 2026, to July 31, 2027, and his subsequent re-appointment from August 1, 2027, to July 31, 2030. The re-appointment and fixation of remuneration for Mr. Shiv Singh Mehta as Chairman and Managing Director for a further term of three years from January 12, 2027, to January 11, 2030, were also approved. All resolutions were passed with the requisite majority.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.